{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:50:32Z","timestamp":1791341432257,"version":"4.3.1"},"reference-count":0,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[1992,8,1]],"date-time":"1992-08-01T00:00:00Z","timestamp":712627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1992,8]]},"abstract":"<jats:p>We tested in vitro the activities of streptomycin and tetracycline--antibiotics that have long been used to treat rhinoscleroma--as well as several newer oral agents by using 23 isolates of the causative organism Klebsiella rhinoscleromatis. All isolates were inhibited by clinically achievable concentrations of trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, chloramphenicol, ciprofloxacin, cephalexin, cefuroxime, and cefpodoxime.<\/jats:p>","DOI":"10.1128\/aac.36.8.1785","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:05:50Z","timestamp":1340841950000},"page":"1785-1787","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":21,"title":["In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis"],"prefix":"10.1128","volume":"36","author":[{"given":"B A","family":"Perkins","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Medical Service, Department of Veterans Affairs Medical Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R J","family":"Hamill","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Medical Service, Department of Veterans Affairs Medical Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Musher","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Medical Service, Department of Veterans Affairs Medical Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"O'Hara","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Medical Service, Department of Veterans Affairs Medical Center, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.36.8.1785","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.36.8.1785","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:29:02Z","timestamp":1645457342000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.36.8.1785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1992,8]]}},"alternative-id":["10.1128\/AAC.36.8.1785"],"URL":"https:\/\/doi.org\/10.1128\/aac.36.8.1785","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,8]]},"assertion":[{"value":"1992-08-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}